|
|  | | | News Feature |  | |
Nature Biotechnology
22, 1343 - 1346 (2004)
doi:10.1038/nbt1104-1343
Biogenerics standoffStephan Herrera
New York
Healthcare costs are out of control. Generic biotech products could ease the pain. What's holding things up? Stephan Herrera investigates.
|
| | |
